SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-026957
Filing Date
2017-05-12
Accepted
2017-05-12 17:24:12
Documents
49
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v466281_10q.htm 10-Q 463753
2 EXHIBIT 31.1 v466281_ex31-1.htm EX-31.1 10711
3 EXHIBIT 31.2 v466281_ex31-2.htm EX-31.2 10324
4 EXHIBIT 32.1 v466281_ex32-1.htm EX-32.1 4092
5 EXHIBIT 32.2 v466281_ex32-2.htm EX-32.2 3998
  Complete submission text file 0001144204-17-026957.txt   2340327

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atxi-20170331.xml EX-101.INS 363959
7 XBRL TAXONOMY EXTENSION SCHEMA atxi-20170331.xsd EX-101.SCH 26295
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20170331_cal.xml EX-101.CAL 19671
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20170331_def.xml EX-101.DEF 158892
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20170331_lab.xml EX-101.LAB 165162
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20170331_pre.xml EX-101.PRE 189384
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-55556 | Film No.: 17840012
SIC: 2834 Pharmaceutical Preparations